Friday, August 19, 2016

Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10g Due to Presence of Iron Oxide Particulate Matter - FDA Safety Alerts & Drug Recalls

Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Oxacillin for Injection, USP, 10 g (NDC 25021-163-99) Lot OXT512 (Exp. Date March 2017) manufactured by Astral SteriTech Private Limited and distributed by Sagent.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2b51Ysj
via IFTTT

No comments:

Post a Comment